Clinical use of drotrecogin alfa (activated): Patients treated in the XEUS study differ from high risk prowess patients
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
10-1-2004
Recommended Citation
Rickert T, Steingrub JS, Cheatham M, Safcsak K, Lipsetts P, Effron M, Linde-Zwirble W, Zeckel M. Clinical use of drotrecogin alfa (activated): Patients treated in the XEUS study differ from high risk prowess patients. Chest 2004. Seattle, WA. Oct 23-Oct 28, 2004.
COinS